| Date Filed | Type | Description |
| 11/19/2021 |
4
| Clayman Michael D. (President and CEO) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Disposed/sold 335,498 shares
@ $8.5, valued at
$2.9M
Disposed/sold 373,769 shares
@ $8.5, valued at
$3.2M
Disposed/sold 24,600 shares
@ $8.5, valued at
$209.1k
Disposed/sold 388,683 shares
@ $8.5, valued at
$3.3M
Disposed/sold 136,530 options to buy
@ $2.52, valued at
$344.1k
Disposed/sold 200,000 options to buy
@ $17.61, valued at
$3.5M
Disposed/sold 110,000 options to buy
@ $22.91, valued at
$2.5M
Disposed/sold 155,000 options to buy
@ $18.2, valued at
$2.8M
Disposed/sold 175,000 options to buy
@ $18.56, valued at
$3.2M
Disposed/sold 116,667 options to buy
@ $22.31, valued at
$2.6M
Disposed/sold 290,000 options to buy
@ $14.75, valued at
$4.3M
|
|
| 07/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/29/2021 |
4
| Clayman Michael D. (President and CEO) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Granted 119,500 shares
@ $0
Paid exercise price by delivering 8,776 shares
@ $12.37, valued at
$108.6k
|
|
| 01/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2020 |
4
| Clayman Michael D. (President and CEO) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Granted 1,303 shares
@ $10.83, valued at
$14.1k
|
|
| 05/27/2020 |
4
| Clayman Michael D. (President and CEO) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Bought 10,256 shares
@ $9.75, valued at
$100k
|
|
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2020 |
4
| Clayman Michael D. (President and CEO) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Gifted 10,398 shares
@ $0
Paid exercise price by delivering 2,494 shares
@ $0
Gifted 5,457 shares
@ $0
Gifted 10,398 shares
@ $0
Gifted 5,457 shares
@ $0 |
|
| 10/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/08/2019 |
4
| Clayman Michael D. (President and CEO) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Bought 2,317 shares
@ $10.8486, valued at
$25.1k
|
|
| 06/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2019 |
4
| Clayman Michael D. (President and CEO) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Bought 4,012 shares
@ $12.4794, valued at
$50.1k
|
|
| 03/13/2019 |
4
| Clayman Michael D. (President and CEO) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Bought 4,046 shares
@ $12.36, valued at
$50k
|
|
| 03/05/2019 |
4
| Clayman Michael D. (President and CEO) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Granted 360,000 options to buy
@ $14.75, valued at
$5.3M
|
|
| 01/04/2019 |
4
| Clayman Michael D. (President and CEO) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Sold 3,278 shares
@ $12.36, valued at
$40.5k
|
|
| 11/13/2018 |
4
| Clayman Michael D. (President and CEO) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Gifted 554 shares
@ $0
Gifted 10,562 shares
@ $0
Gifted 8,567 shares
@ $0
Bought 5,000 shares
@ $17.0953, valued at
$85.5k
Gifted 554 shares
@ $0
Gifted 10,562 shares
@ $0
Gifted 8,567 shares
@ $0 |
|
| 10/09/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2018 |
4
| Clayman Michael D. (President and CEO) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Bought 10,000 shares
@ $22.33, valued at
$223.3k
|
|
| 06/22/2018 |
4
| Clayman Michael D. (President and CEO) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Acquired 554 shares
@ $21.22, valued at
$11.8k
|
|
| 06/15/2018 |
4
| Clayman Michael D. (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $11.14, valued at
$139.3k
|
|
| 02/02/2018 |
4
| Clayman Michael D. (President and CEO) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Granted 29,167 shares
@ $0
Granted 116,667 options to buy
@ $22.31, valued at
$2.6M
|
|
| 12/22/2017 |
4
| Clayman Michael D. (President and CEO) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Acquired 166 shares
@ $16.59, valued at
$2.8k
|
|
| 11/09/2017 |
4
| Clayman Michael D. (President and CEO) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Bought 5,000 shares
@ $23.6, valued at
$118k
|
|
| 10/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/27/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/22/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|